RSPO1 and pulmonary fibrosis: As we refine understanding of the responsive cell types, we will construct WNT and RSPO mimetics that target epitopes on select individual or groups of cell types [57, 72] with the goal of developing therapies that repair pulmonary fibrosis with limited systemic liabilities.